In 1988, the World Health Organization defined MMFCC as a tumor that displays the morphological features of both medullary and follicular carcinomas with immunoreactivity for calcitonin and thyroglobulin, respectively [2]. The gene discussed is CALCA; the disease is thyroid gland follicular carcinoma.